Event Details Replimune Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma Conference Call Jun 6, 2024 at 8:00 AM EDT Click here for webcast Supporting Materials Replimune Primary Analysis of the IGNYTE Registrational Cohort Presentation June 2024 4.5 MB Print Page RSS Feeds RSS Feeds Email Alerts Email Alerts Contact IR Contact IR Search Search
Replimune Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma Conference Call Jun 6, 2024 at 8:00 AM EDT Click here for webcast Supporting Materials Replimune Primary Analysis of the IGNYTE Registrational Cohort Presentation June 2024 4.5 MB
